RECURSION PHARMACEUTICALS, INC. (RXRX)
Nasdaq: RXRX · CIK 0001601830 · United States
Every official RECURSION PHARMACEUTICALS, INC. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open RXRX filings
RECURSION PHARMACEUTICALS, INC. documents
- RECURSION PHARMACEUTICALS, INC. 10-K 2026RXRX 10-K 2026: annual report for fiscal 2026
- RECURSION PHARMACEUTICALS, INC. 10-K 2025RXRX 10-K 2025: annual report for fiscal 2025
- RECURSION PHARMACEUTICALS, INC. 10-K 2024RXRX 10-K 2024: annual report for fiscal 2024
- RECURSION PHARMACEUTICALS, INC. 10-K 2023RXRX 10-K 2023: annual report for fiscal 2023
- RECURSION PHARMACEUTICALS, INC. 10-K 2022RXRX 10-K 2022: annual report for fiscal 2022
- RECURSION PHARMACEUTICALS, INC. 10-Q 2026RXRX 10-Q 2026: quarterly report for fiscal 2026
- RECURSION PHARMACEUTICALS, INC. 10-Q 2025RXRX 10-Q 2025: quarterly report for fiscal 2025
- RECURSION PHARMACEUTICALS, INC. 10-Q 2024RXRX 10-Q 2024: quarterly report for fiscal 2024
- RECURSION PHARMACEUTICALS, INC. 10-Q 2023RXRX 10-Q 2023: quarterly report for fiscal 2023
- RECURSION PHARMACEUTICALS, INC. 10-Q 2022RXRX 10-Q 2022: quarterly report for fiscal 2022
- RECURSION PHARMACEUTICALS, INC. 8-K 2026RXRX 8-K 2026: current report for fiscal 2026
- RECURSION PHARMACEUTICALS, INC. 8-K 2025RXRX 8-K 2025: current report for fiscal 2025
- RECURSION PHARMACEUTICALS, INC. 8-K 2024RXRX 8-K 2024: current report for fiscal 2024
- RECURSION PHARMACEUTICALS, INC. 8-K 2023RXRX 8-K 2023: current report for fiscal 2023
- RECURSION PHARMACEUTICALS, INC. 8-K 2022RXRX 8-K 2022: current report for fiscal 2022
- RECURSION PHARMACEUTICALS, INC. DEF 14A 2026RXRX DEF 14A 2026: proxy statement for fiscal 2026
- RECURSION PHARMACEUTICALS, INC. DEF 14A 2025RXRX DEF 14A 2025: proxy statement for fiscal 2025
- RECURSION PHARMACEUTICALS, INC. DEF 14A 2024RXRX DEF 14A 2024: proxy statement for fiscal 2024
- RECURSION PHARMACEUTICALS, INC. DEF 14A 2023RXRX DEF 14A 2023: proxy statement for fiscal 2023
- RECURSION PHARMACEUTICALS, INC. DEF 14A 2022RXRX DEF 14A 2022: proxy statement for fiscal 2022
- RECURSION PHARMACEUTICALS, INC. Form 4 2026RXRX Form 4 2026: insider trading filing for fiscal 2026
- RECURSION PHARMACEUTICALS, INC. Form 4 2025RXRX Form 4 2025: insider trading filing for fiscal 2025
- RECURSION PHARMACEUTICALS, INC. Form 4 2024RXRX Form 4 2024: insider trading filing for fiscal 2024
- RECURSION PHARMACEUTICALS, INC. Form 4 2023RXRX Form 4 2023: insider trading filing for fiscal 2023
- RECURSION PHARMACEUTICALS, INC. Form 4 2022RXRX Form 4 2022: insider trading filing for fiscal 2022
- RECURSION PHARMACEUTICALS, INC. S-1 2026RXRX S-1 2026: registration statement for fiscal 2026
- RECURSION PHARMACEUTICALS, INC. S-1 2025RXRX S-1 2025: registration statement for fiscal 2025
- RECURSION PHARMACEUTICALS, INC. S-1 2024RXRX S-1 2024: registration statement for fiscal 2024
- RECURSION PHARMACEUTICALS, INC. S-1 2023RXRX S-1 2023: registration statement for fiscal 2023
- RECURSION PHARMACEUTICALS, INC. S-1 2022RXRX S-1 2022: registration statement for fiscal 2022
- RECURSION PHARMACEUTICALS, INC. 13F 2026RXRX 13F 2026: institutional holdings for fiscal 2026
- RECURSION PHARMACEUTICALS, INC. 13F 2025RXRX 13F 2025: institutional holdings for fiscal 2025
- RECURSION PHARMACEUTICALS, INC. 13F 2024RXRX 13F 2024: institutional holdings for fiscal 2024
- RECURSION PHARMACEUTICALS, INC. 13F 2023RXRX 13F 2023: institutional holdings for fiscal 2023
- RECURSION PHARMACEUTICALS, INC. 13F 2022RXRX 13F 2022: institutional holdings for fiscal 2022
More companies